Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Christine Bellon

General Counsel at Beam Therapeutics Inc. (BEAM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $881K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 6SEC BEAMBeam Therapeutics Inc. Sell Plan 5,956109,711 held (−5%) $24.58 $146K +4.6%
Jan 26SEC BEAMBeam Therapeutics Inc. Sell Plan 1,37195,667 held (−1%) $34.00 $47K -24.4%
Jan 20SEC BEAMBeam Therapeutics Inc. Sell Plan 2,111113,556 held (−2%) $33.62 $71K -23.6%
Jan 20SEC BEAMBeam Therapeutics Inc. Sell Plan 15,95997,597 held (−14%) $34.72 $554K -26.0%
Jan 20SEC BEAMBeam Therapeutics Inc. Sell Plan 55997,038 held (−1%) $35.40 $20K -27.4%
Jan 5SEC BEAMBeam Therapeutics Inc. Sell Plan 1,254115,667 held (−1%) $27.10 $34K -5.2%
Oct 3SEC BEAMBeam Therapeutics Inc. Sell Plan 373116,921 held (−0%) $24.53 $9K +4.8%
  • Sell

    General Counsel Christine Bellon sold $146K of BEAM at $24.58 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Christine Bellon sold $47K of BEAM at $34.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Christine Bellon sold $71K of BEAM at $33.62 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Christine Bellon sold $554K of BEAM at $34.72 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Christine Bellon sold $20K of BEAM at $35.40 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Christine Bellon sold $34K of BEAM at $27.10 — pre-scheduled 10b5-1 plan sale.